Gene Query: NSUN5

Dataset Description Geneva Score
Peptidomimetic blockade of MYB in acute myeloid leukemia 37.7
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 37.7
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 27.17
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 22.33
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 20.11
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 19.46
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 17.08
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 14.91
Gene expression changes associated with resistance to tagraxofusp (SL-401) 14.37
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 14.26
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 13.62
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 13.57
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 13.35
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 13.34
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 13.34
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 13.14
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 13.13
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 13.01
Seletive inhibition of CDK9 in DLBCL cell lines 13.0
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 12.43
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 12.28
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 11.91
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 11.26
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 11.25
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 10.43
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 10.19
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 10.16
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 10.04
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 9.55
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 9.54
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 9.45
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 9.37
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 9.29
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 9.22
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 9.11
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 9.04
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 8.5
Cajal bodies are linked to genome conformation [RNA-Seq] 8.5
Cajal bodies are linked to genome conformation 8.5
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 8.39
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 8.27
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 8.15
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 7.97
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 7.81
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 7.81
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 7.8
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 7.75
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 7.56
Chromatin-informed inference of transcriptional programs in gynecologic cancers 7.56
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 7.56
RNA-seq analyisis of PUM2 knockout cells 7.54
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 7.52
RNA-seq analysis of AML cells in response to ASLAN003 7.5
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 7.42
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 7.36
Global expression profiles in cardiac progenitor cells generated by ISX-9 7.34
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 7.34
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 7.23
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.21
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 7.13
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 7.13
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 7.11
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 7.11
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 7.09
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 7.09
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 7.02
Differential gene expression of human melanoma cells [RNA-seq] 7.02
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 6.7
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 6.58
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 6.58
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 6.58
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.54
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 6.54
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 6.51
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 6.5
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 6.5
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 6.5
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.47
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 6.43
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 6.36
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 6.36
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 6.32
RNA-seq in transgenic cells 6.29
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 6.28
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 6.28
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 6.19
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 6.11
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 6.1
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 6.08
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 6.07
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 6.07
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 6.04
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.93
hTERT promotes cell adhesion and migration independent of telomerase activity 5.92
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 5.89
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 5.89
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 5.87
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.84
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 5.82
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 5.82
Spliceosomal disruption of the non-canonical BAF complex in cancer 5.81
HNF1A deficiency impairs β-cell fate, granule maturation and function 5.74
Genome wide expression change by RNF168 knocking down in MCF-7 cells 5.71
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 5.66
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 5.64
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 5.64
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 5.61
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 5.61
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 5.52
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.5
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 5.48
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 5.46
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.28
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.28
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 5.26
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 5.24
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 5.24
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 5.15
RNA-seq of naive and primed ES cells 5.14
RNA-seq analysis of control and Myc-induced U2OS cells 5.12
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 5.12
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 5.11
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 5.11
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 5.11
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 5.11
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 5.09
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 5.09
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 5.07
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 5.07
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 5.05
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 5.02
RNA sequencing with KSHV infection and enrichment for circular RNAs 5.02
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 5.01
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.01
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 4.96
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 4.95
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 4.95
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 4.91
Paxillin regulates genomic networks in prostate cancer [PC3] 4.9
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 4.89
SRSF2 mutations impair hematopoiesis and alter exon recognition 4.89
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 4.88
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 4.82
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 4.79
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 4.79
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 4.77
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 4.77
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 4.73
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.72
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.71
Illumina Total RNA-seq in HeLa 4.69
Silencing p300 in MCF7 cells to study expression and alternative splicing 4.68
The cohesin complex prevents Myc-induced replication stress 4.57
Global analysis of enhancer targets: Mosaic-seq 4.53
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 4.52
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 4.52
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 4.49
High-throughput sequencing of pluripotent cells 4.46
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.46
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 4.43
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 4.43
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 4.42
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 4.42
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 4.42
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 4.42
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 4.42
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 4.41
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 4.41
Impact of dieldrin on transcription in Jurkat T cells 4.41
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.41
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 4.41
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 4.4
Hijacking of stress response machinery by oncogenes in acute leukaemia 4.4
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.4
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 4.4
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 4.4
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 4.38
SUV420H2 knockdown in PANC-1 4.38
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 4.38
Transcriptome analysis of H9 hESC derived cerebral organoids 4.37
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 4.33
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.32
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 4.32
RNA-seq of human aneuploid cell lines with Trisomy 21 4.32
EP400 is required for Max and MCPyV mediated gene activation 4.3
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 4.27
Cleavage Factor Im as a key regulator of 3’ UTR length 4.27
Direct Isolation and Characterization of Human Nephron Progenitors. 4.26
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 4.26
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 4.22
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 4.22
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.18
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 4.18
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 4.14
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 4.12
ETV7 and interferon response 4.12
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 4.07
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.06
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.05
RNA-seq of YB5 cells treated with Proscillaridin A 4.04
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.03
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 4.03
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 4.02
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 4.0
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.98
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 3.97
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 3.97
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 3.97
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 3.97
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 3.94
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 3.94
Identification of HOXB13 target genes responsive to BET inhibitors 3.94
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.94
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 3.93
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 3.93
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.9
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 3.89
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 3.89
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 3.87
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 3.86
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 3.86
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 3.86
RNAseq of cell lines with knocked in ESR1 mutations 3.86
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 3.86
Survival of pancreatic cancer cells lacking KRAS function 3.85
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 3.76
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 3.74
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 3.74
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 3.73
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 3.72
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.69
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.69
Characterization of parental and rociletinib-resistant derived H1975 cell lines 3.69
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 3.68
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.68
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.68
TAF1 is critical for AE driven leukemogenesis 3.65
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 3.65
Effect of PBK knockdown on C4-2 cell transcriptome 3.65
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.64
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.64
AMPK signaling for naïve pluripotency 3.64
AMPK signaling for naïve pluripotency [Hs] 3.64
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.63
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 3.63
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 3.62
ENCODE Cold Spring Harbor Labs Long RNA-seq 3.59
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.59
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 3.53
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.49
RNA splicing alteration on glioblastoma and normal neural stem cells 3.47
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 3.42
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.41
DAOY-Notch1/Notch2 knockout: transcriptome comparison 3.4
Global gene expression profile of dasatinib-resistant RCH-ACV cells 3.39
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 3.39
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.37
SRSF1 role in cellular gene expression and splicing 3.36
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 3.35
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 3.35
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 3.35
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.34
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.34
Transcriptome analysis of SKI knock-out in HL60 cells 3.34
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.32
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.32
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 3.31
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.29
N6-methyladenine DNA Modification in Glioblastoma 3.29
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 3.25
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 3.23
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 3.22
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 3.22
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 3.22
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.2
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 3.19
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 3.11
PRDM1 inhibits proliferation of human colon cancer organoids 3.08
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.08
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 3.07
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 3.07
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 3.07
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 3.06
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 3.05
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 3.02
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 3.02
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 3.02
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 2.99
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 2.99
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.98
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.97
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 2.96
Gene expression and genome-wide location analysis of breast cancer cell-lines 2.94
Gene expression analysis of breast cancer cell-lines 2.94
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 2.93
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 2.93
Studying the selectivity of a small molecule Synucleozid on transcriptome 2.91
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.88
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 2.85
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.83
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.81
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.81
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.8
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 2.8
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 2.79
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.76
Effect of FGF13 depletion on the H460 cell line 2.7
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 2.69
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.69
Regulation of poly(A) tail and translation during the somatic cell cycle 2.68
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.65
IRF1 regulates IFN dependent and independent gene expression 2.63
Tpl-2 and MEK small molecule inhibitors 2.57
Tpl-2 small molecule project 2.57
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.53
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.53
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 2.5
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.48
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.46
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.46
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 2.45
Functional significance of the HIV-1 Tat signature amino acid residues 2.42
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 2.36
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 2.35
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 2.34
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 2.34
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 2.31
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 2.3
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 2.3
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.3
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 2.27
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 2.26
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 2.22
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 2.18
Gene expression profiling of leukemia cells following asparagine depletion 2.16
Clinker: visualizing fusion genes detected in RNA-seq data 2.13
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.11
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.1
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.08
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 2.05
The transcriptome effect of overexpressing EZH2 in MCF7 2.03
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 2.01
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.0
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 2.0
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 1.99
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 1.98
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.96
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.96
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 1.95
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.94
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.92
Molecular Criteria for Defining the Naive Human Pluripotent State 1.84
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.83
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.83
RNA sequencing of human mammary epithelial cells 1.81
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.81
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.81
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.8
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 1.79
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.71
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.7
Single-Cell Genotyping of Transcriptomes 1.69
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.69
Effect of drugs on transcriptomic profiles 1.66
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.64
FBXW7 modulates stress response by post-translational modification of HSF1 1.63
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 1.63
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.63
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.62
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 1.61
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.6
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.58
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.57
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.57
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 1.56
Human cells contain natural double-stranded RNAs with potential regulatory capacity 1.56
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.55
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 1.54
RNA-Seq of PRMT1 overexpression ECA109 cells 1.53
Silencing SPIB in attached and floating state of H1703 lung cancer cells 1.53
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.53
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.51
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.51
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 1.48
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.45
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.4
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.4
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 1.4
Primary Human B-cell Temporal Response to CD40L Stimulation 1.39
NR2F2 study 1.37
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 1.37
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.34
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 1.31
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.27
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 1.25
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.21
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.21
Energy Metabolism during Anchorage-Independence 1.21
TT-Seq captures the human transient transcriptome 1.21
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 1.2
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.2
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.2
Transcriptome sequencing of K-562 cells 1.19
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.16
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.16
ChIP-seq and RNA-seq from human lymphoma cell lines 1.13
RNA-seq data from human lymphoma cell lines 1.13
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.11
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.09
RNA seq with AML (NB4) cells upon FTO inhibition 1.08
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.07
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.07
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.05
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.05
KLF6-dependent transcription in renal cancer cells 1.04
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.04
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.04
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.99
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.98
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.96
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.95
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.89
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.88
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.88
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.88
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.85
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.85
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.85
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.83
Active translatome profiling with RiboLace in MCF7 cells 0.82
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.81
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.77
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.76
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.74
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 0.74
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.73
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.73
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.73
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.7
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.7
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.7
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.69
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.69
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.68
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.66
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.66
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.66
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.65
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.64
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.6
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.59
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.57
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.55
Downregulation of LATS kinases alters p53 to promote cell migration 0.55
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.54
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.53
Gene expression analysis upon mtDNA depletion 0.53
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.53
RNA-Seq from human ILC transitional populations 0.51
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.51
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.5
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.48
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.45
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.44
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.44
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.38
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.38
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 0.37
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.33
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.33
H1609088 Human RNA-Sequencing 0.3
MARS Seq data from human cortical organoids 0.29
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 0.27
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 0.27
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.26
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.25
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.24
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.24
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.22
Myc activation coordinates gene transcription and protein translation responses 0.22
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.22
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.22
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.17
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.17
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.17
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.15
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.11
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.11
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.09
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.08
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.08
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.07
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.06
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.04
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.04
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.04
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.04
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.04
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.01
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation